missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PLAGL1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5106792
This item is not returnable.
View return policy
Description
Antibody detects endogenous levels of total PLAGL1.
This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activities. It has been shown to have anti-proliferative properties, and thus thought to function as a tumor suppressor. In addition, overexpression of this gene during fetal development is believed to underlie the rare disorder, transient neonatal diabetes mellitus (TNDM). This gene is imprinted, with preferential expression of the paternal allele in many tissues, however, biallelic expression has been noted in peripheral blood leucocytes. A recent study reports that tissue-specific imprinting results from variable utilization of monoallelic and biallelic promoters. Many transcript variants differing in the 5' UTR and encoding two different isoforms, have been found for this gene.
Specifications
| PLAGL1 | |
| Polyclonal | |
| Unconjugated | |
| Plagl1 | |
| Lost on transformation 1; LOT1; LOT-1; PLAG1 like zinc finger 1; PLAGL1; PLAG-like 1; pleiomorphic adenoma gene-like 1; Pleiomorphic adenoma-like protein 1; Tumor suppressor ZAC; ZAC; Zac1; zinc finger protein PLAGL1; zinc finger protein regulator of apoptosis and cell cycle arrest; zinc finger protein Zac 1 | |
| Rabbit | |
| Affinity Chromatography | |
| RUO | |
| 25157, 5325 | |
| -20°C | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q9UM63 | |
| Plagl1 | |
| A synthesized peptide derived from human PLAGL1(Accession Q9UM63), corresponding to amino acid residues P312-P362. | |
| 100 μL | |
| Primary | |
| Human, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction